Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Wirelessly Powered Implant Targets Excess Glucose in the Blood

By HospiMedica International staff writers
Posted on 28 Oct 2026

Type 2 diabetes is a chronic metabolic disorder that is becoming increasingly common worldwide. More...

It is often associated with obesity, sedentary behavior, and prolonged excess energy intake. Although insulin lowers blood sugar, it does not address the chronic energy surplus that can contribute to continued weight gain. To help manage excess circulating glucose, researchers have developed an implantable electronic system designed to remove it from the blood.

Developed by ETH Zurich researchers as a potential treatment approach for type 2 diabetes, the system uses an electrically powered inorganic catalyst rather than cells, enzymes, or other biological components. The findings were published in Science on October 22, 2026.

The catalyst works by converting excess blood glucose into gluconate, removing some glucose from further metabolism and reducing its storage in tissue. The resulting gluconate is then excreted in the urine.

To carry out this conversion, the implant incorporates graphite felt studded with gold nanoclusters and decorated with smaller platinum particles. An electronic control unit sits inside a 3D-printed casing, while power is supplied wirelessly at 13.56 MHz, a frequency designated internationally for industrial, scientific, and medical applications.

Catalyst activity is managed through a wireless closed-loop system. A standard glucose sensor continuously monitors tissue glucose and sends a Bluetooth signal to a smartphone or smartwatch when blood sugar rises too high after a meal. The smart device then activates the catalyst, with the implant switching off automatically once glucose reaches the desired level.

The team first tested the catalyst in a reservoir containing five liters of glucose-containing nutrient solution, roughly equivalent to the volume of blood in the human body. It converted glucose in this volume as intended. In separate tests in diabetic mice, the complete system precisely regulated blood sugar, supported weight loss, was well tolerated, and operated reliably over six weeks.

“The system operates at a very low voltage, and our experiments showed no evidence of tissue damage from either electrical or thermal effects,” said Martin Fussenegger, professor in ETH Zurich’s Department of Biosystems Science and Engineering in Basel.

“For decades, we have treated diabetes by telling the body how to manage glucose. We are now showing that we can take control of glucose directly, using electronics rather than drugs. And the catalyst only activates when glucose levels are too high,” said Fussenegger.

Related Links
ETH Zurich


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Monitor/Defibrillator
Zenix
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.